Connecticut § 38a-479sss Annual report by commissioner to the General Assembly re outpatient prescription drug costs.

Connecticut Statutes

§ 38a-479sss — Annual report by commissioner to the General Assembly re outpatient prescription drug costs.

Connecticut § 38a-479sss

Title 38aInsurance

Ch. 700cHealth Insurance

This text of Connecticut § 38a-479sss (Annual report by commissioner to the General Assembly re outpatient prescription drug costs.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 38a-479sss (2026).

Text

Not later than March 1, 2022, and annually thereafter, the commissioner shall submit a report, in accordance with section 11-4a, to the joint standing committee of the General Assembly having cognizance of matters relating to insurance. The report shall contain (1) an aggregation of the information and data submitted to the commissioner pursuant to section 38a-479qqq for the immediately preceding calendar year, (2) a description of the impact of the cost of outpatient prescription drugs on health insurance premiums in this state, and (3) such other information as the commissioner, in the commissioner's discretion, deems relevant to the cost of outpatient prescription drugs in this state.

Free access — add to your briefcase to read the full text and ask questions with AI

Not later than March 1, 2022, and annually thereafter, the commissioner shall submit a report, in accordance with section 11-4a, to the joint standing committee of the General Assembly having cognizance of matters relating to insurance. The report shall contain (1) an aggregation of the information and data submitted to the commissioner pursuant to section 38a-479qqq for the immediately preceding calendar year, (2) a description of the impact of the cost of outpatient prescription drugs on health insurance premiums in this state, and (3) such other information as the commissioner, in the commissioner's discretion, deems relevant to the cost of outpatient prescription drugs in this state.